Considering that panobinostat is a pan-HDACi, future experiments will investigate the role of specific HDAC isoforms in mediating increases in histone acetylation in response to panobinostat, as well as to determine the potential of HDACi against in vivo models of IDH1mut gliomas. Here, HDAC9 is linked to glioma.